Difference between revisions of "Main Page"

From HealthNLP-Cancer
Jump to: navigation, search
(Who We Are)
(Scrum Sprints)
(384 intermediate revisions by 13 users not shown)
Line 1: Line 1:
 +
<!-- == Public Site ==
 +
'''Please visit our Cancer Deep Phenotype (DeepPhe) ''public site'' at [http://healthnlp.hms.harvard.edu/deepphe/wiki http://deepphe.healthnlp.org].''' -->
  
== Welcome to the Cancer Deep Phenotype Extraction (DeepPhe) project ==
+
 
Welcome to the Cancer Deep Phenotype Extraction (DeepPhe) project.
+
== Welcome to the Cancer Deep Phenotype Extraction project ==
 +
Our goal is to develop novel methods for information extraction to facilitate automatic/unsupervised/minimally supervised extraction of specific discrete cancer-related data from various types of unstructured electronic medical records. Our two main use cases are cancer deep phenotyping for translational science (DeepPhe) and a platform for cancer surveillance by the cancer registries (DeepPhe*CR)
 +
 
 +
<!-- Welcome to the Cancer Deep Phenotype Extraction (DeepPhe) project.
  
 
Cancer is a genomic disease, with enormous heterogeneity in its behavior. In the past, our methods for categorization, prediction of outcome, and treatment selection have relied largely on a morphologic classification of Cancer. But new technologies are fundamentally reframing our views of cancer initiation, progression, metastasis, and response to treatment; moving us towards a molecular classification of Cancer. This transformation depends not only on our ability to deeply investigate the cancer genome, but also on our ability to link these specific molecular changes to specific tumor behaviors. As sequencing costs continue to decline at a supra-Moore’s law rate, a torrent of cancer genomic data is looming. However, our ability to deeply investigate the cancer genome is outpacing our ability to correlate these changes with the phenotypes that they produce. Translational investigators seeking to associate specific genetic, epigenetic, and systems changes with particular tumor behaviors, lack access to detailed observable traits about the cancer (the so called ‘deep phenotype’), which has now become a major barrier to research.
 
Cancer is a genomic disease, with enormous heterogeneity in its behavior. In the past, our methods for categorization, prediction of outcome, and treatment selection have relied largely on a morphologic classification of Cancer. But new technologies are fundamentally reframing our views of cancer initiation, progression, metastasis, and response to treatment; moving us towards a molecular classification of Cancer. This transformation depends not only on our ability to deeply investigate the cancer genome, but also on our ability to link these specific molecular changes to specific tumor behaviors. As sequencing costs continue to decline at a supra-Moore’s law rate, a torrent of cancer genomic data is looming. However, our ability to deeply investigate the cancer genome is outpacing our ability to correlate these changes with the phenotypes that they produce. Translational investigators seeking to associate specific genetic, epigenetic, and systems changes with particular tumor behaviors, lack access to detailed observable traits about the cancer (the so called ‘deep phenotype’), which has now become a major barrier to research.
Line 7: Line 12:
 
We propose the advanced development and extension of a software platform for performing deep phenotype extraction directly from medical records of patients with Cancer, with the goal of enabling translational cancer research and precision medicine. The work builds on previous informatics research and software development efforts from Boston Children’s Hospital and University of Pittsburgh groups, both individually and together. Multiple software projects developed by our groups (some initially funded by NCI) that have already passed the initial prototyping and pilot development phase (eMERGE, THYME, TIES, ODIE, Apache cTAKES) will be combined and extended to produce an advanced software platform for accelerating cancer research. Previous work in a number of NIH-funded translational science initiatives has already demonstrated the benefits of these methodologies (e.g. Electronic Medical Record and Genomics (eMERGE), PharmacoGenomics Research Network (PGRN), SHARPn, i2b2). However, to date these initiatives have focused exclusively on select non-cancer phenotypes and have had the goal of dichotomizing patients for a particular phenotype of interest (for example, Type II Diabetes, Rheumatoid Arthritis, or Multiple Sclerosis). In contrast, our proposed work focuses on extracting and representing multiple phenotype features for individual patients, to build a cancer phenotype model, relating observable traits over time for individual patients.
 
We propose the advanced development and extension of a software platform for performing deep phenotype extraction directly from medical records of patients with Cancer, with the goal of enabling translational cancer research and precision medicine. The work builds on previous informatics research and software development efforts from Boston Children’s Hospital and University of Pittsburgh groups, both individually and together. Multiple software projects developed by our groups (some initially funded by NCI) that have already passed the initial prototyping and pilot development phase (eMERGE, THYME, TIES, ODIE, Apache cTAKES) will be combined and extended to produce an advanced software platform for accelerating cancer research. Previous work in a number of NIH-funded translational science initiatives has already demonstrated the benefits of these methodologies (e.g. Electronic Medical Record and Genomics (eMERGE), PharmacoGenomics Research Network (PGRN), SHARPn, i2b2). However, to date these initiatives have focused exclusively on select non-cancer phenotypes and have had the goal of dichotomizing patients for a particular phenotype of interest (for example, Type II Diabetes, Rheumatoid Arthritis, or Multiple Sclerosis). In contrast, our proposed work focuses on extracting and representing multiple phenotype features for individual patients, to build a cancer phenotype model, relating observable traits over time for individual patients.
  
Our first four development specific aims significantly extend the capability of our current software, focusing on challenging problems in biomedical information extraction. These aims support the development and evaluation of novel methods for cancer deep phenotype extraction:
+
Our aims support the development and evaluation of novel methods for cancer deep phenotype extraction:
  
Specific Aim 1: Develop methods for extracting phenotypic profiles. Extract patient’s deep phenotypes, and their attributes such as general modifiers (negation, uncertainty, subject) and cancer specific characteristics (e.g. grade, invasion, lymph node involvement, metastasis, size, stage)
+
Develop methods for extracting phenotypic profiles.
  
Specific Aim 2: Extract gene/protein mentions and their variants from the clinical narrative
+
Extract gene/protein mentions and their variants from the clinical narrative
  
Specific Aim 3: Create longitudinal representation of disease process and its resolution. Link phenotypes, treatments and outcomes in temporal associations to create a longitudinal abstraction of the disease
+
Create longitudinal representation of disease process and its resolution
  
Specific Aim 4: Extract discourses containing explanations, speculations, and hypotheses, to support explorations of causality
+
Design and implement a computational platform for deep phenotype discovery and analytics for translational investigators, including integrative visual analytics.
  
Our last two implementation specific aims focus on the design of the software to support the cancer research community, ensuring the usability and utility of our software. These aims support the design, dissemination and sharing of the products of this work to maximize impact on cancer research:
+
Advance translational research in driving cancer biology research projects in breast cancer, ovarian cancer, and melanoma. Include research community throughout the design of the platform and its evaluation. Disseminate freely available software.
 
+
Specific Aim 5: Design and implement a computational platform for deep phenotype discovery and analytics for translational investigators, including integrative visual analytics.
+
 
+
Specific Aim 6: Advance translational research in driving cancer biology research projects in breast cancer, ovarian cancer, and melanoma. Include research community throughout the design of the platform and its evaluation. Disseminate freely available software.
+
 
+
Impact: The proposed work will produce novel methods for extracting detailed phenotype information directly from the EMR, the major source of such data for patients with cancer. Extracted phenotypes will be used in three ongoing translational studies with a precision medicine focus. Dissemination of the software will enhance the ability of cancer researchers to abstract meaningful clinical data for translational research. If successful, systematic capture and representation of these phenotypes from EMR data could later be used to drive clinical genomic decision support.
+
  
 +
Impact: The proposed work will produce novel methods for extracting detailed phenotype information directly from the EMR, the major source of such data for patients with cancer. Extracted phenotypes will be used in three ongoing translational studies with a precision medicine focus. Dissemination of the software will enhance the ability of cancer researchers to abstract meaningful clinical data for translational research. If successful, systematic capture and representation of these phenotypes from EMR data could later be used to drive clinical genomic decision support. -->
  
  
 
== Who We Are ==
 
== Who We Are ==
* Boston Childrens Hospital/Harvard Medical School
+
===Boston Children's Hospital/Harvard Medical School===
** Guergana Savova (MPI)
+
* [https://www.childrenshospital.org/research/researchers/guergana-savova Guergana Savova] (MPI for DeepPhe and DeepPhe*CR)
** Dmitriy Dligach
+
* Timothy Miller
** Timothy Miller
+
* Sean Finan
** Sean Finan
+
* David Harris
** David Harris
+
* Chen Lin
** Pei Chen
+
* past members -- Dmitriy Dligach (currently faculty at Loyola University, Chicago), James Masanz
** Chen Lin
+
  
* University of Pittburgh
+
===University of Pittburgh===
** Rebecca Crowley Jacobson (MPI)
+
* [https://www.phdl.pitt.edu/people/harry-hochheiser-phd Harry Hochheiser] (MPI for DeepPhe and DeepPhe*CR)
** Harry Hochheiser
+
* Zhou Yuan
** Roger Day
+
* John Levander
** Adrian Lee
+
* past members - through June 2017: Rebecca Crowley Jacobson (MPI), Roger Day, Adrian Lee, Robert Edwards, John Kirkwood, Kevin Mitchell, Eugene Tseytlin, Girish Chavan, Melissa Castine; Liz Legowski (through Jan 2015), Olga Medvedeva, Mike Davis
** Robert Edwards
+
** John Kirkwood
+
** Kevin Mitchell
+
** Eugene Tseytlin
+
** Girish Chavan
+
** Liz Legowski (through Jan 2015)
+
  
== Funding ==
+
===Rhode Island Hospital (Brown University)===
The project described is supported by Grant Number 1U24CA184407-01 from the National Cancer Institute at the US National Institutes of Health. This work is part of the NCI's Informatics Technology for Cancer Research (ITCR) Initiative (http://itcr.nci.nih.gov/) The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
+
* [https://vivo.brown.edu/display/jwarne11 Jeremy Warner] (MPI for DeepPhe and DeepPhe*CR)
 +
* [https://vivo.brown.edu/display/dgamsiz Ece Uzun]
 +
* [https://vivo.brown.edu/display/dsdizon Don Dizon]
 +
* Sandeep Jain
 +
* Alex VanHelene
  
The project period is May 2014 - April, 2019.
+
===University of Kentucky/Kentucky Cancer Registry===
 +
* Eric Durbin (MPI for DeepPhe*CR)
 +
* Isaac Hands
 +
* Jong Jeong
 +
* Ramakanth (Rama) Kavuluru
 +
* David Rust
 +
* Lisa Witt
  
 +
===Dana-Farber Cancer Institute===
 +
* [https://www.dana-farber.org/find-a-doctor/elizabeth-i-buchbinder Elizabeth Buchbinder]
 +
* [https://www.dana-farber.org/find-a-doctor/danielle-s-bitterman Danielle Bitterman]
  
 +
===University of Minnesota===
 +
* Piet de Groen
  
== Publications and presentations crediting DeepPhe ==
+
===Vanderbilt University===
* Hochheiser H; Jacobson R; Washington N; Denny J; Savova G. 2015. Natural language processing for phenotype extraction: challenges and representation. AMIA Annual Symposium. Nov 2015, San Francisco, CA.
+
* [https://www.vumc.org/viiii/person/douglas-b-johnson-md-msci Douglas B. Johnson]
* Dmitriy Dligach, Timothy Miller, Guergana K. Savova. 2015. Semi-supervised Learning for Phenotyping Tasks. AMIA Annual Symposium. Nov 2015, San Francisco, CA.
+
* past members - Alicia Beeghly-Fadiel
  
 +
== Funding ==
 +
The project described is supported by the National Cancer Institute at the US National Institutes of Health. It is part of the National Cancer Institute's Informatics Technology for Cancer Research (ITCR) Initiative (http://itcr.nci.nih.gov/) and the Surveillance, Epidemiology, and End Results Program (SEER; https://seer.cancer.gov/) at the US National Cancer Institute (NCI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
  
  
== DeepPhe Software ==
+
== Cancer Deep Phenotyping for Cancer Surveillance (DeepPhe*CR) ==
The DeepPhe system will be available as part of Apache cTAKES at http://ctakes.apache.org/. It is also available at https://github.com/DeepPhe/DeepPhe.
+
=== Scrum Sprints ===
 +
*[[Year1_goals_DeepPheCR | Goals DeepPhe-CR July 2019 - June 2020]]
 +
**[[ScrumSprint_DeepPheCR | Sprint 1 DeepPhe-CR, August 2019]]
 +
**[[ScrumSprint_DeepPheCR_2 | Sprint 2 DeepPhe-CR, Sept 19 - Oct 17, 2019]]
 +
**[[ScrumSprint_DeepPheCR_3 | Sprint 3 DeepPhe-CR, Oct 18 - Nov 14, 2019]]
 +
**[[ScrumSprint_DeepPheCR_4 | Sprint 4 DeepPhe-CR, Nov 14 - Jan 9, 2020]]
 +
**[[ScrumSprint_DeepPheCR_5 | Sprint 5 DeepPhe-CR, Jan 9 - Feb 6, 2020]]
 +
**[[ScrumSprint_DeepPheCR_6 | Sprint 6 DeepPhe-CR, Feb 7 - Mar 5, 2020]]
 +
**[[ScrumSprint_DeepPheCR_7 | Sprint 7 DeepPhe-CR, Mar 6 - Apr 2, 2020]]
 +
**[[ScrumSprint_DeepPheCR_8 | Sprint 8 DeepPhe-CR, Apr 3 - Apr 30, 2020]]
 +
**[[ScrumSprint_DeepPheCR_9 | Sprint 9 DeepPhe-CR, May 1 - May 28, 2020]]
 +
**[[ScrumSprint_DeepPheCR_10 | Sprint 10 DeepPhe-CR, May 29 - July 9, 2020]]
  
DeepPhe software components will also be deployed in the TIES Software System for sharing and accessing deidentified NLP-processed data with tissue(http://ties.pitt.edu/) which is deployed as part of the TIES Cancer Tissue Network (TCRN) across multiple US Cancer Centers.
+
* [[Year2_goals_DeepPheCR | Goals DeepPhe-CR July 2020 - June 2021]]
 +
**[[ScrumSprint_DeepPheCR_11 | Sprint 11 DeepPhe-CR, July 16 - Aug 13, 2020]]
 +
**[[ScrumSprint_DeepPheCR_12 | Sprint 12 DeepPhe-CR, Aug 13 - Sept 10, 2020]]
 +
**[[ScrumSprint_DeepPheCR_13 | Sprint 13 DeepPhe-CR, Sept 10 - Oct 14, 2020]]
 +
**[[ScrumSprint_DeepPheCR_14 | Sprint 14 DeepPhe-CR, Oct 15 - Nov 12, 2020]]
 +
**[[ScrumSprint_DeepPheCR_15 | Sprint 15 DeepPhe-CR, Nov 13, 2020 - Jan 14, 2021]]
 +
**[[ScrumSprint_DeepPheCR_16 | Sprint 16 DeepPhe-CR, Jan 14 - Feb 18, 2021]]
 +
**[[ScrumSprint_DeepPheCR_17 | Sprint 17 DeepPhe-CR, Feb 18 - Mar 25, 2021]]
 +
**[[ScrumSprint_DeepPheCR_18 | Sprint 18 DeepPhe-CR, Mar 25 - April 28, 2021]]
 +
**[[ScrumSprint_DeepPheCR_19 | Sprint 19 DeepPhe-CR, Apr 29 - May 27, 2021]]
 +
**[[ScrumSprint_DeepPheCR_20 | Sprint 20 DeepPhe-CR, May 28 - Jun 30, 2021]]
  
DeepPhe software development will be coordinated as per [[DeepPhe_code_repositories_and_policies | software development policies]].
+
* [[Year3_goals_DeepPheCR | Goals DeepPhe-CR July 2021 - June 2022]]
 +
**[[ScrumSprint_DeepPheCR_21 | Sprint 21 DeepPhe-CR, Aug 5 - Sept 8, 2021]]
 +
**[[ScrumSprint_DeepPheCR_22 | Sprint 22 DeepPhe-CR, Sept 9 - Oct 7, 2021]]
 +
**[[ScrumSprint_DeepPheCR_23 | Sprint 23 DeepPhe-CR, Oct 14 - Nov 11, 2021]]
 +
**[[ScrumSprint_DeepPheCR_24 | Sprint 24 DeepPhe-CR, Nov 12 - Dec 9, 2021]]
 +
**[[ScrumSprint_DeepPheCR_25 | Sprint 25 DeepPhe-CR, Dec 10, 2021 - Jan 13, 2022]]
 +
**[[ScrumSprint_DeepPheCR_26 | Sprint 26 DeepPhe-CR, Jan 14 - Feb 10, 2022]]
 +
**[[ScrumSprint_DeepPheCR_27 | Sprint 27 DeepPhe-CR, Feb 11 - Mar 10, 2022]]
 +
**[[ScrumSprint_DeepPheCR_28 | Sprint 28 DeepPhe-CR, Mar 11 - April 8, 2022]]
 +
**[[ScrumSprint_DeepPheCR_29 | Sprint 29 DeepPhe-CR, April 8 - May 5, 2022]]
 +
**[[ScrumSprint_DeepPheCR_30 | Sprint 30 DeepPhe-CR, May 6 - June 2, 2022]]
 +
**[[ScrumSprint_DeepPheCR_31 | Sprint 31 DeepPhe-CR, June 3 - 30, 2022]]
  
 +
* [[Year4_goals_DeepPheCR | Goals DeepPhe-CR July 2022 - June 2023]]
 +
**[[ScrumSprint_DeepPheCR_32 | Sprint 32 DeepPhe-CR, July 1 - 28, 2022]]
 +
**[[ScrumSprint_DeepPheCR_33 | Sprint 33 DeepPhe-CR, July 29 - Aug 25, 2022]]
 +
**[[ScrumSprint_DeepPheCR_34 | Sprint 34 DeepPhe-CR, Aug 26 - Sept 22, 2022]]
 +
**[[ScrumSprint_DeepPheCR_35 | Sprint 35 DeepPhe-CR, Sept 23 - Oct 20, 2022]]
 +
**[[ScrumSprint_DeepPheCR_36 | Sprint 36 DeepPhe-CR, Oct 21 - Nov 24, 2022]]
 +
**[[ScrumSprint_DeepPheCR_37 | Sprint 37 DeepPhe-CR, Nov 25, 2022 - Jan 5, 2023]]
 +
**[[ScrumSprint_DeepPheCR_38 | Sprint 37 DeepPhe-CR, Jan 6 - Feb 2, 2023]]
 +
**[[ScrumSprint_DeepPheCR_39 | Sprint 39 DeepPhe-CR, Feb 3 - Mar 2, 2023]]
 +
**[[ScrumSprint_DeepPheCR_40 | Sprint 40 DeepPhe-CR, Mar 3 - 30, 2023]]
 +
**[[ScrumSprint_DeepPheCR_41 | Sprint 41 DeepPhe-CR, Mar 31 - Apr 27, 2023]]
 +
**[[ScrumSprint_DeepPheCR_42 | Sprint 42 DeepPhe-CR, Apr 28 - May 25, 2023]]
 +
**[[ScrumSprint_DeepPheCR_43 | Sprint 43 DeepPhe-CR, May 26 - June 30, 2023]]
  
 +
* [[Year5_goals_DeepPheCR | Goals DeepPhe-CR July 2023 - June 2024]]
 +
**[[ScrumSprint_DeepPheCR_44 | Sprint 44 DeepPhe-CR, Jul 1 - Aug 3, 2023]]
 +
**[[ScrumSprint_DeepPheCR_45 | Sprint 45 DeepPhe-CR, Aug 3 - 31, 2023]]
 +
**[[ScrumSprint_DeepPheCR_46 | Sprint 46 DeepPhe-CR, Sept 1 - 28, 2023]]
 +
**[[ScrumSprint_DeepPheCR_47 | Sprint 47 DeepPhe-CR, Sept 29 - Oct 26, 2023]]
 +
**[[ScrumSprint_DeepPheCR_48 | Sprint 48 DeepPhe-CR, Oct 27 - Nov 30, 2023]]
 +
**[[ScrumSprint_DeepPheCR_49 | Sprint 49 DeepPhe-CR, Dec 1, 2023 - Jan 4, 2024]]
 +
**[[ScrumSprint_DeepPheCR_50 | Sprint 50 DeepPhe-CR, Jan 5 - Feb 1, 2024]]
 +
**[[ScrumSprint_DeepPheCR_51 | Sprint 51 DeepPhe-CR, Feb 2 - 29, 2024]]
 +
**[[ScrumSprint_DeepPheCR_52 | Sprint 52 DeepPhe-CR, Mar 1 - 29, 2024]]
 +
**[[ScrumSprint_DeepPheCR_53 | Sprint 53 DeepPhe-CR, Mar 29 - Apr 26, 2024]]
  
== DeepPhe Gold Set ==
+
=== Project materials ===
* [[Deidentification_Process | Process for Deidentification of Source Documents]].
+
*[[UG3 Technical Details]]
* [[Gold_Set_Selection | Process for Selection of Gold Set Source Documents]].
+
*[[Registry Integration User Stories]]
* Training/Development/Test splits
+
*[[Technical Topics]]
** training set: all documents for Breast Cancer patients 03, 11, 92, 93 for a total of 48 documents
+
** development set: all documents for Breast Cancer patients 02, 21 for a total of 42 documents
+
** test set: all documents for Breast Cancer patients 01, 16 for a total of 41 documents
+
** use the training set for developing the algorithms and the development set to report results and error analysis. The test set will be used only for the final evaluation to go in publications.
+
  
 +
=== Publications and presentations ===
 +
Peer-reviewed publications:
 +
#'''2023:''' Bitterman DS, Goldner E, Finan S, Harris D, Durbin EB, Hochheiser H, Warner JL, Mak RH, Miller T, Savova GK. An End-to-End Natural Language Processing System for Automatically Extracting Radiation Therapy Events From Clinical Texts. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):262-273. doi: 10.1016/j.ijrobp.2023.03.055. Epub 2023 Mar 27. PMID: 36990288; PMCID: PMC10522797.
 +
#'''2020:''' Durbin, Eric; Hochheiser , Harry; Petkov, Valentina; Rivera, Donna; Savova, Guergana; Warner, Jeremy. 2020. Tools and software to automate and normalize the cancer data abstraction workflow. Workshop at the annual North American Association of Cancer Registries (NAACCR). June 2020. Philadelphia, PA.
 +
#'''2020:''' Zhou Yuan, Sean Finan, Jeremy Warner, Guergana Savova, Harry Hochheiser 2019. Interactive Exploration of Longitudinal Cancer Patient Histories Extracted From Clinical Text. JCO Clin Cancer Inform. 2020 May;4:412-420. doi: 10.1200/CCI.19.00115
 +
#'''2019:''' Guergana Savova, Ioana Danciu, Folami Alamudun, Timothy Miller, Chen Lin, Danielle S Bitterman, Georgia Tourassi and Jeremy L Warner. 2019. Use of Natural Language Processing to Extract Clinical Cancer Phenotypes from Electronic Medical Records. Cancer Research. doi: 10.1158/0008-5472.CAN-19-0579
  
 +
Pre-prints:
 +
#'''2023:''' Hochheiser H, Finan S, Yuan Z, Durbin EB, Jeong JC, Hands I, Rust D, Kavuluru R, Wu XC, Warner JL, Savova G. DeepPhe-CR: Natural Language Processing Software Services for Cancer Registrar Case Abstraction. medRxiv [Preprint]. 2023 Oct 26:2023.05.05.23289524. doi: 10.1101/2023.05.05.23289524. PMID: 37205575; PMCID: PMC10187451.
  
== Qualitative Interviews ==
+
Presentations:
* [[User_Personae | Detailed Stakeholder Descriptions]].  
+
#'''2019:''' Savova, Guergana and Hochheiser, Harry. “Cancer Deep Phenotype Extraction from Electronic Medical Records ”. Data Science Seminar Series. National Cancer Institute, National Institutes of Health. Oct 2019.
* [[Interview_Protocol | Interview Protocol]]
+
#'''2019:''' Warner, Jeremy, Durbin, Eric, Petkov, Valentina and Savova, Guergana. 2019. Tools and Software to Automate and Normalize the Cancer Data Abstraction Workflow.  Workshop at 2019 Conference of the North American Association of Central Cancer Registries and the International Association of Cancer Registries. June 9-13, 2019. Vancouver, BC, Canada
* [[Media:Cd-quick-intro-201408110918.pdf|Contextual Design Notes]]
+
* [[Informant_Interviews | Notes on interviews with informants]]
+
  
 +
=== Websites ===
 +
* https://github.com/DeepPhe
 +
* https://github.com/DeepPhe/DeepPhe -- private code repository
 +
* https://github.com/DeepPhe/cr-neo4j-plugin
 +
* https://github.com/DeepPhe/docker
 +
* https://github.com/DeepPhe/cr-rest-api
 +
* https://github.com/DeepPhe/deepphe-owl
  
 +
== Cancer Deep Phenotyping for Translational Science (DeepPhe) ==
 +
=== Publications and presentations ===
 +
Peer-reviewed publications:
 +
<ul>
 +
  <ol>
 +
<li> Lin, Chen; Miller, Timothy; Dligach, Dmitriy; Amiri, Hadi; Bethard, Steven and Savova, Guergana. 2018. Self-training improves Recurrent Neural Networks performance for Temporal Relation Extraction. LOUHI 2018: The Ninth International Workshop on Health Text Mining and Information Analysis. Oct 31-Nov 1, 2018. Brussels, Belgium.
 +
https://aclanthology.coli.uni-saarland.de/papers/W18-5619/w18-5619 </li>
  
== Project materials/ WIKIs to tasks ==
+
<li>Malty, Andrew M., Jain, Sandeep K., Yang, Peter C., Harvey, Krysten, Warner, Jeremy L. Computerized approach to creating a systematic ontology of hematology/oncology regimens. JCO Clinical Cancer Informatics. 2018 May 11.
* Liquid Planner link (project management): https://app.liquidplanner.com/space/26220/dashboard
+
http://ascopubs.org/doi/full/10.1200/CCI.17.00142 </li>
* [[Stakeholder_templates | Templates]] for describing stakeholders.
+
<li>Miller, Timothy; Dligach, Dmitriy; Bethard, Steven; Lin, Chen; Savova, Guergana. 2017. Towards Generalizable Entity-Centric Clinical Coreference Resolution. Journal of Biomedical Informatics. Vol. 69, May 2017, pp. 251-258. https://doi.org/10.1016/j.jbi.2017.04.015; http://www.sciencedirect.com/science/article/pii/S1532046417300850</li>
* [[DeepPhe_code_repositories_and_policies | Software development policies and repositories]].  
+
<li>Castro SM, Tseytlin E, Medvedeva O, Mitchell K, Visweswaran S, Bekhuis T, Jacobson RS. 2017. Automated annotation and classification of BI-RADS assessment from radiology reports. J Biomed Inform. 2017 May;69:177-187. doi: 10.1016/j.jbi.2017.04.011. PMID: 28428140; PMCID: PMC5706448 [Available on 2018-05-01] DOI:10.1016/j.jbi.2017.04.011
* [[Deep_Phe_data_repository_and_policies | Data Repository and Policies]].
+
https://www.sciencedirect.com/science/article/pii/S1532046417300813 </li>
* [[Adopted Standards and Conventions for NLP annotations | Adopted Standards and Conventions for NLP annotations (task 1.4.2)]]
+
<li>Lin, Chen; Miller, Timothy; Dligach, Dmitriy; Bethard, Steven; Savova, Guergana. 2017. Representations of Time Expressions for Temporal Relation Extraction with Convolutional Neural Networks. BioNLP workshop at the Association for Computational Linguistics conference. Vancouver, Canada, Friday August 4, 2017.
* [[Gold_Set_Selection | Gold Set Selection]]
+
https://aclanthology.coli.uni-saarland.de/papers/W17-2341/w17-2341 </li>
* Modeling
+
<li>Miller, T; Bethard, S; Amiri, H; Savova, G. 2017. Unsupervised Domain Adaptation for Clinical Negation Detection. BioNLP workshop at the Association for Computational Linguistics conference. Vancouver, Canada, Friday August 4, 2017
**[[Rules]]
+
https://aclanthology.coli.uni-saarland.de/papers/W17-2320/w17-2320 </li>
** [[Cancer_phenotype_modeling_notes| Cancer phenotype modeling]] notes
+
<li>Savova, G., Tseytlin, E., Finan, S., Castine, M., Miller, T., Medvedeva, O., Haris, D., Hochheiser, H., Lin, C., Chavan, G., Jacobson R. 2017. DeepPhe - A Natural Language Processing System for Extracting Cancer Phenotypes from Clinical Records. Annual Symposium of the American Medical Informatics Association (AMIA). Nov 2017. Washington DC
** [[Layered cancer phenotyping]]
+
https://amia2017.zerista.com/event/member/389439 </li>
***[[Episode modeling]]
+
<li>Savova, G., Tseytlin, E., Finan, S., Castine, M., Miller, T., Medvedeva, O., Haris, D., Hochheiser, H., Lin, C., Chavan, G., Jacobson R. 2017. DeepPhe: A Natural Language Processing System for Extracting Cancer Phenotypes from Clinical Records. Cancer Research 77(21), November 2017 DOI: 10.1158/0008-5472.CAN-17-0615.
** [http://www.hl7.org/implement/standards/fhir/ FHIR]  modeling
+
https://www.ncbi.nlm.nih.gov/pubmed/29092954</li>
***[[FHIR_Cancer_examples| FHIR Cancer examples]]
+
<li>Dligach, Dmitriy; Miller, Timothy; Lin, Chen; Bethard, Steven; Savova, Guergana. 2017. Neural temporal relation extraction. European Chapter of the Association for Computational Linguistics (EACL 2017). April 3-7, 2017. Valencia, Spain.
***[[FHIR_General_questions| General questions regarding FHIR usage]]
+
https://aclanthology.coli.uni-saarland.de/papers/E17-2118/e17-2118 </li>
***[[FHIR_Unresolved| Unresolved Questions to be addressed in FHIR models]]
+
<li>Chen, Lin; Miller, Timothy; Dligach, Dmitriy; Bethard, Steven; Savova, Guergana. 2016. Improving Temporal Relation Extraction with Training Instance Augmentation. BioNLP workshop at the Association for Computational Linguistics conference. Berlin, Germany, Aug 2016
***[[FHIR and RDF]]
+
https://aclanthology.coli.uni-saarland.de/papers/W16-2914/w16-2914 </li>
***[[FHIR Value Sets]]
+
<li>Hochheiser, Harry; Castine, Melissa; Harris, David; Savova, Guergana; Jacobson, Rebecca. 2016. An Information Model for Computable Cancer Phenotypes. BMC Medical Informatics and Decision Making.
** Domain Modeling Notes/Questions
+
https://bmcmedinformdecismak.biomedcentral.com/articles/10.1186/s12911-016-0358-4
*** [[Breast Cancer Domain Notes/Questions]]
+
https://www.ncbi.nlm.nih.gov/pubmed/27629872 </li>
** [[Cancer_phenotype_model_validation | Validation of models with domain experts]]
+
<li>Ethan Hartzell, Chen Lin. 2016. Enhancing Clinical Temporal Relation Discovery with Syntactic Embeddings from GloVe. International Conference on Intelligent Biology and Medicine (ICIBM 2016). Medical Informatics Thematic Track. December 2016, Houston, Texas, USA</li>
** [[Comptency_questions|Competency questions]] to be used for validation of models.  
+
<li>Dmitriy Dligach, Timothy Miller, Guergana K. Savova. 2015. Semi-supervised Learning for Phenotyping Tasks. AMIA Annual Symposium. Nov 2015, San Francisco, CA.
** [[Representational_issues| Representations]] of the models.  
+
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765699/ </li>
** Historical pages
+
<li>Chen, Lin; Dligach, Dmitriy; Miller, Timothy; Bethard, Steven; Savova, Guergana. 2015. Multilayered temporal modeling for the clinical domain. Journal of the American Medical Informatics Association. 2016 Mar;23(2):387-95. doi: 10.1093/jamia/ocv113
*** [[CEM_Cancer_phenotype_models| CEM Cancer phenotype models]]: models describing the original CEM Models
+
https://www.ncbi.nlm.nih.gov/pubmed/26521301 </li>
 
+
</ol>
* [[Visual Analytics]]
+
</ul>
**[[User_Stories | User Stories]]
+
 
* [[Informant Interviews]]
+
Peer-reviewed other:
** [[User Challenges]]
+
<ul>
* [[Technical Infrastructure]]
+
  <ol>
* [[ Deep_learing | Deep Learning]]
+
<li>Beeghly-Fadiel, Alicia; Warner, Jeremy; Finan, Sean; Masanz, James;  Hochheiser, Harry; Savova, Guergana. (under review). Deep Phenotype Extraction to Facilitate Cancer Research: Extending DeepPhe to Ovarian Cancer. American Association for Cancer Research (AACR) 2019. March 29-April 3, 2019. Atlanta, GA.</li>
* [[ Cross_document_coreference | Cross document coreference]]
+
<li>Yuan, Zhou; Finan, Sean; Warner, Jeremy; Savova, Guergana; Hochheiser, Harry. 2018. Toward Longitudinal Visual Analytics for Cancer Patient Trajectories Extracted from Clinical Text. 2018 Workshop on Visual Analytics and Healthcare, Demonstration Presentation. AMIA 2018, Nov 3-7, 2018. San Francisco, CA.</li>
* [[ Summarization_Logic | Summarization Logic]]
+
<li>Chen Lin, Timothy A. Miller, Hadi Amiri, David Harris, Samuel M. Rubinstein, Jeremy Warner, Guergana K. Savova, Ph.D. 2018. Classification of electronic medical records of breast cancer and melanoma patients into clinical episodes. 30th Anniversary AACR Special Conference Convergence: Artificial Intelligence, Big Data, and Prediction of Cancer. Oct 14-17, 2018. Newport, RI, USA.</li>
* [[ Architecture | Architecture]]
+
<li>Warner, Jeremy; Elhadad, Noemie; Bastarache, Lisa; Gotz, David; Savova, Guergana. 2018. Panel - Didactic: Computable Longitudinal Patient Trajectories. Annual Symposium of the American Medical Informatics Association. November, 2018. San Francisco, CA. (peer-reviewed panel)</li>
* [[ SoftwareBestPractices | Software Best Practices]]
+
<li>Savova G, Tseytlin E, Finan S, Castine M, Miller T, Medvedeva O, Harris D, Hochheiser H, Lin C, Chavan G, Warner JL, Jacobson R. DeepPhe – a natural language processing system for extracting cancer phenotypes from clinical records. Annual conference of the North American Association of Central Cancer Registries (NAACCR). Pittsburgh, PA.</li>
* [[ Gold_standard_annotations| Gold standard annotations]]
+
<li>Warner JL, Harris D, Rubinstein S, Finan S, Lin C, Miller T, Amiri H, Hochheiser H, Savova G. Capturing high-resolution temporal cancer phenotypes using DeepPhe. Annual conference of the North American Association of Central Cancer Registries (NAACCR). Pittsburgh, PA.</li>
* [[ Licensing| Licensing]]
+
<li>Yang PC, Malty A, Jain SK, Harvey K, Finan S, Warner JL. 2018. A Comprehensive Ontology of Hematology/Oncology Regimens. Annual conference of the North American Association of Central Cancer Registries (NAACCR). Pittsburgh, PA.</li>
* [[Year2_Goals| Year 2 goals]]
+
<li>Hochheiser H; Jacobson R; Washington N; Denny J; Savova G. 2015. Natural language processing for phenotype extraction: challenges and representation. AMIA Annual Symposium. Nov 2015, San Francisco, CA. (peer-reviewed panel)</li>
 +
</ol>
 +
</ul>
  
 +
Invited presentations:
 +
<ul>
 +
  <ol>
 +
<li>Savova, Guergana. 2019. Cancer Deep Phenotype Extraction from Electronic Medical Records. Molecular Med Tri-con. March 10-15, 2019. San Francisco, CA, USA </li>
 +
<li>Savova G. 2018. Software and Research Challenges for Clinical NLP. Dana Farber Cancer Institute; 2018 October; Boston, MA, USA. </li>
 +
<li>Savova, Guergana. 2018. Cancer Deep Phenotype Extraction form Electronic Medical Records (DeepPhe). College of American Pathologists Pathology Electronic Reporting meeting (CAP PERT). July 29, 2018. Montreal, QB, CA. </li>
 +
<li>Warner, Jeremy. 2018. A Comprehensive Ontology of Hematology/Oncology Regimens. College of American Pathologists Pathology Electronic Reporting meeting (CAP PERT). July 29, 2018. Montreal, QB, CA. </li>
 +
<li>Savova, G; Miller, T. 2018. DeepPhe and Extraction of Oncology Patient Phenotypes from Unstructured Text Using NLP and Other AI Tools. Presentation to Dana Farber Cancer Institute. January 24 2018. Boston, MA.</li>
 +
<li>Warner, Jeremy. 2017. Supporting cancer registries through automated extraction of pathology and chemotherapy regimen information.” CDC/NCI/FDA/VA Clinical Natural Language Processing Workshop. Atlanta, GA. </li>
 +
<li>Savova, Guergana. 2017. Select Applications of Natural Language Processing in Biomedicine. Natural Language Processing Symposium, Boston University, Boston, MA. November, 2017. </li>
 +
<li>Jacobson, Rebecca. 2017. Invited presentation at Ohio State University James Cancer Center Grand Rounds, January 20th, 2017</li>
 +
<li>Jacobson, Rebecca. 2017. Invited presentation at Case Western University Comprehensive Cancer Center Seminar Series, March 10th, 2017</li>
 +
<li>Jacobson, Rebecca. 2016. Invited presentation of cTAKES and DeepPhe to NCI in January, 2016. Gaithersburg, MD</li>
 +
<li>Jacobson, Rebecca. 2016. Invited presentation in CBIIT Speaker Series, February 17, 2016. Gaithersburg, MD</li>
 +
<li>Jacobson, Rebecca. 2016. Invited presentation at University of Pittsburgh Cancer Informatics (UPCI) External Advisory Board, March 8, 2016</li>
 +
<li>Finan, Sean. 2016. cTAKES/deepPhe presentation at the ITCR workshop at CI4CC in Napa, CA</li>
 +
<li>Jacobson, Rebecca. 2016. Invited presentation at SEER PI meeting in New Mexico, March 16, 2016</li>
 +
<li>Jacobson, Rebecca. 2016. Invited presentation at University of Michigan Department of Learning Health Sciences, April 6th, 2016</li>
 +
<li>Jacobson, Rebecca. 2016. Invited presentation at Pathology Informatics 2016, Pittsburgh PA, May 24th, 2016</li>
 +
<li>Jacobson, Rebecca. 2016. Invited presentation at University of Pittsburgh Cancer Institute Scientific Retreat, Greensburg, PA, June 16th, 2016</li>
 +
<li>Jacobson, Rebecca and Savova, Guergana. 2016. Invited presentation at SEER meeting in Gaithersburg, MD, December 10, 2016</li>
 +
<li>Jacobson, Rebecca and Savova, Guergana. Invited presentation of cTAKES/DeepPhe to NCI in October, 2015</li>
 +
</ol>
 +
</ul>
  
 +
Other:
 +
<ul>
 +
  <ol>
 +
<li>Interview with Uduak Thomas of the GenomeWeb magazine. May 16, 2014. https://www.genomeweb.com/informatics/upitt-bch-team-use-696k-grant-develop-nlp-based-tools-extract-phenotype-data-emr#.W3HF1NJKi70 </li>
 +
<li>Project website: cancer.healhnlp.org </li>
 +
<li>Github repository: https://github.com/DeepPhe </li>
 +
<li>Listed on the ITCR website, Tools: https://itcr.cancer.gov/informatics-tools </li>
 +
</ol>
 +
</ul>
  
'''Presentations'''
+
<!--# Hochheiser H; Jacobson R; Washington N; Denny J; Savova G. 2015. Natural language processing for phenotype extraction: challenges and representation. AMIA Annual Symposium. Nov 2015, San Francisco, CA.
 +
# Dmitriy Dligach, Timothy Miller, Guergana K. Savova. 2015. Semi-supervised Learning for Phenotyping Tasks. AMIA Annual Symposium. Nov 2015, San Francisco, CA.
 +
# Lin, Chen; Dligach, Dmitriy; Miller, Timothy; Bethard, Steven; Savova, Guergana. 2015. Layered temporal modeling for the clinical domain. Journal of the American Medical Informatics Association. http://jamia.oxfordjournals.org/content/early/2015/10/31/jamia.ocv113
 +
# Lin, Chen; Miller, Timothy; Dligach, Dmitriy; Bethard, Steven; Savova, Guergana. 2016. Improving Temporal Relation Extraction with Training Instance Augmentation. BioNLP workshop at the Association for Computational Linguistics conference. Berlin, Germany, Aug 2016
 +
# Timothy A. Miller, Sean Finan, Dmitriy Dligach, Guergana Savova. Robust Sentence Segmentation for Clinical Text. Abstract presented at the Annual Symposium of the American Medical Informatics Association, San Francisco, CA, 2015.
 +
# Hochheiser, Harry; Castine, Melissa; Harris, David; Savova, Guergana; Jacobson, Rebecca. 2016. An Information Model for Cancer Phenotypes. BMC Medical Informatics and Decision Making. https://bmcmedinformdecismak.biomedcentral.com/articles/10.1186/s12911-016-0358-4
 +
# Ethan Hartzell, Chen Lin. 2016. Enhancing Clinical Temporal Relation Discovery with Syntactic Embeddings from GloVe. International Conference on Intelligent Biology and Medicine (ICIBM 2016). December 2016, Houston, Texas, USA
 +
# Dligach, Dmitriy; Miller, Timothy; Lin, Chen; Bethard, Steven; Savova, Guergana. 2017. Neural temporal relation extraction. European Chapter of the Association for Computational Linguistics (EACL 2017). April 3-7, 2017. Valencia, Spain.
 +
# Lin, Chen; Miller, Timothy; Dligach, Dmitriy; Bethard, Steven; Savova, Guergana. 2017. Representations of Time Expressions for Temporal Relation Extraction with Convolutional Neural Networks. BioNLP workshop at the Association for Computational Linguistics conference. Vancouver, Canada, Friday August 4, 2017
 +
# Timothy A. Miller,  Dmitriy Dligach, Chen Lin, Steven Bethard, Guergana Savova. Feature Portability in Cross-domain Clinical Coreference. Abstract presented at the Annual Symposium of the American Medical Informatics Association, Chicago, IL, 2016.
 +
# Castro SM, Tseytlin E, Medvedeva O, Mitchell K, Visweswaran S, Bekhuis T, Jacobson RS. 2017. Automated annotation and classification of BI-RADS assessment from radiology reports. J Biomed Inform. 2017 May;69:177-187. doi: 10.1016/j.jbi.2017.04.011. PMID: 28428140; PMCID: PMC5706448 [Available on 2018-05-01] DOI:10.1016/j.jbi.2017.04.011
 +
# Timothy A. Miller, Steven Bethard, Hadi Amiri, Guergana Savova. Unsupervised Domain Adaptation for Clinical Negation Detection. Proceedings of the 16th Workshop on Biomedical Natural Language Processing. 2017.
 +
# Timothy A. Miller, Dmitriy Dligach, Steven Bethard, Chen Lin, and Guergana Savova. Towards generalizable entity-centric coreference resolution. Journal of Biomedical Informatics, 69; 251-258. 2017.
 +
# Lin, Chen; Miller, Timothy; Dligach, Dmitriy; Bethard, Steven; Savova, Guergana. 2017. Representations of Time Expressions for Temporal Relation Extraction with Convolutional Neural Networks. BioNLP workshop at the Association for Computational Linguistics conference. Vancouver, Canada, Friday August 4, 2017
 +
# Miller, T; Bethard, S; Amiri, H; Savova, G. 2017. Unsupervised Domain Adaptation for Clinical Negation Detection. BioNLP workshop at the Association for Computational Linguistics conference. Vancouver, Canada, Friday August 4, 2017
 +
# Savova, G., Tseytlin, E., Finan, S., Castine, M., Miller, T., Medvedeva, O., Haris, D., Hochheiser, H., Lin, C., Chavan, G., Jacobson R. 2017. DeepPhe: A Natural Language Processing System for Extracting Cancer Phenotypes from Clinical Records Cancer Research 77(21), November 2017 DOI: 10.1158/0008-5472.CAN-17-0615.
 +
# Savova, G., Tseytlin, E., Finan, S., Castine, M., Miller, T., Medvedeva, O., Haris, D., Hochheiser, H., Lin, C., Chavan, G., Jacobson R. 2017. DeepPhe - A Natural Language Processing System for Extracting Cancer Phenotypes from Clinical Records. Annual Symposium of the American Medical Informatics Association (AMIA). Nov 2017. Washington DC.
 +
# Savova, G; Miller, T. 2018. DeepPhe and Extraction of Oncology Patient Phenotypes from Unstructured Text Using NLP and Other AI Tools. Presentation to Dana Farber Cancer Institute. January  24 2018. Boston, MA.
 +
# Warner, Jeremy. 2018. Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging and Pathology Expertise and Technologies. the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine. http://www.nationalacademies.org/hmd/Activities/Disease/NCPF/2018-FEB-12/Videos/Session%204%20Videos/32%20Warner.aspx -->
  
* How to effectively use LiquidPlanner for DeepPhe: https://www.dropbox.com/s/1f6nkhx3yxh4v9q/LiquidPlanner%20for%20Deep-Phe.pptx
+
=== Information Extracted by DeepPhe ===
* DeepPhe Rule Driven Architectures: https://www.dropbox.com/s/hl70zkvjs1ftt5a/DeepPhe%20Rule%20Driven%20Architectures.pptx
+
* Cancer – body location, laterality, stage, clinical TNM, path TNM
 +
* Tumor – body location, laterality, diagnosis, tumor type, histologic type, cancer type, extend, grade
 +
* Specific to BrCA – clockface position, quadrant, ER/PR/HER2
 +
* Specific to OvCa – CA-125
 +
* Specific to melanoma – clarks level, Breslow depth
 +
* Specific to prostate cancer -- Gleason score, PSA
 +
* Medications
 +
* Procedures
 +
* Radiotherapy
 +
* Comorbidities
 +
* Episodes –
 +
** Pre-diagnostic: a tumor is mentioned PRIOR to a malignant diagnosis
 +
** Diagnostic: a tumor is mentioned WITH a malignant diagnosis
 +
** Decision making: discussion of potential treatments AFTER an established diagnosis
 +
** Treatment: a treatment is mentioned DURING the treatment episode
 +
** Follow-up: discussion appearing AFTER the treatment episode ends
 +
** Unknown: episode category unsettled
  
 +
=== DeepPhe Software ===
 +
<!-- The DeepPhe system will be available as part of Apache cTAKES at http://ctakes.apache.org/. It is now available at https://github.com/DeepPhe/DeepPhe-Release and https://github.com/DeepPhe/DeepPhe-Viz.
  
 +
DeepPhe software components will also be deployed in the TIES Software System for sharing and accessing deidentified NLP-processed data with tissue(http://ties.pitt.edu/) which is deployed as part of the TIES Cancer Tissue Network (TCRN) across multiple US Cancer Centers.
  
== Communication ==
+
DeepPhe software development will be coordinated as per [[DeepPhe_code_repositories_and_policies | software development policies]]. -->
* Bi-weekly team meetings
+
* Tools we use for communication are listed in our [[Communications_Plan |Communications Plan ]].
+
  
 +
DeepPhe release is available in
 +
<!--* [[ctakes_api | ctakes api]]-->
 +
* [https://github.com/DeepPhe/DeepPhe-Release code]
  
 +
=== DeepPhe Gold Set ===
 +
* [[Deidentification_Process | Process for Deidentification of Source Documents]].
 +
* [[Public_Deidentification_Process | Process for Deidentification of Source Documents]].
 +
* [[Public:Deidentification_Process | Process for Deidentification of Source Documents]].
 +
* [[Gold_Set_Selection | Process for Selection of Gold Set Source Documents]].
 +
* DepPhe Training/Development/Test splits
 +
** training set:
 +
*** all documents for Breast Cancer patients 03, 11, 92, 93 for a total of 48 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev\DeepPhe Gold Phenotype Annotations_v2.xlsm
 +
*** all documents for Breast Cancer patients extended 4,5,6,9,10,12,13,14,18,19,20,22,23,26,27,30,31,32,33,34,35,38,39,40,41,42,43,46,47 for a total of 954 documents  (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev\DeepPhe Gold Phenotype Annotations_v2.xlsm
 +
*** all documents for Melanoma patients 05, 06, 18, 19, 25, 28, 30, 33, 34, 42, for a total of 233 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\melanoma); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\melanoma\trainSet\DeepPhe DevSet Phenotype Annotations.xlsm
 +
*** all documents for Ovarian Cancer patients 3, 4, 7, 8, 12, 13, 16, 17, 18, 20, 24, 25, 26, 27, 30, 31, 32, 34, 37, 38, 41, 42, 43, 44, 46, 48 for a total of 1675 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\ovarian\final_dataset\trainSet); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\ovarian\final_dataset\trainSet\DeepPhe_ovCa_Train_Set_Phenotype_Annotations_GOLD.xlsm
 +
*** all documents for Colorectal cancer patients 1, 2, 3, 8, 9, 10, 11, 16, 17, 18, 19, 24, 25, 26, 27, 32, 33, 34, 35, 40, 41, 42, 43, 48, 49, 50, 51, 56, 57, 58, 59, 64, 65, 66, 67, 72, 73, 74, 75, 80, 81, 82, 83, 88, 89, 90, 91, 96, 97, 98, 99, 104, 105, 106, 107, 112, 113, 114, 115, 120, 121, 122, 123, 128, 129, 130, 131, 136, 137, 138, 139, 144, 145, 146, 147, 152, 153, 154, 155, 160, 161, 162, 163, 168, 169, 170, 171, 176, 177, 178, 179, 184, 185, 186, 187, 192, 193, 194, 195, 200, 201, 202, 203, 208, 209, 210, 211, 216, 217
 +
** development set:
 +
*** all documents for Breast Cancer patients 02, 21 for a total of 42 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev\DeepPhe Gold Phenotype Annotations_v2.xlsm
 +
*** all documents for Breast Cancer patients extended 7,8,15,16,17,24,25,28,29,36,37,44,45 for a total of 457 documents  (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev\DeepPhe Gold Phenotype Annotations_v2.xlsm
 +
*** all documents for Melanoma patients 07, 32, 43 for a total of 215 (processed only 211 docs) documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\melanoma\devSet); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\melanoma\devSet\DeepPhe DevSet Phenotype Annotations.xlsm
 +
*** all documents for Ovarian Cancer patients 9, 11, 19, 28, 29, 35, 39, 47 for a total of 562 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\ovarian\final_dataset\devSet); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\ovarian\final_dataset\devSet\DeepPhe_ovCa_Dev_Set_Phenotype_Annotations_GOLD.xlsm
 +
*** all documents for Colorectal cancer patients 4, 5, 12, 13, 20, 21, 28, 29, 36, 37, 44, 45, 52, 53, 60, 61, 68, 69, 76, 77, 84, 85, 92, 93, 100, 101, 108, 109, 116, 117, 124, 125, 132, 133, 140, 141, 148, 149, 156, 157, 164, 165, 172, 173, 180, 181, 188, 189, 196, 197, 204, 205, 212, 213
 +
** test set:
 +
*** all documents for Breast Cancer patients 01 (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedTest); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedTest\DeepPhe Test Phenotype Annotations v2.xlsm
 +
*** all documents for Breast Cancer extended for patients 01, 02, 63, 76, 100, 101, 104, 106, 109, 111, 114, 115, 117, 118, 119, 120, 121, 123, 125, 126, 129, 130, 132, 136, 137, 138, 142, 143, 155, 156, 158, 174, 181, 189, 197 for phenotyping level testing use (\\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedTest\); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedTest\DeepPhe Test Phenotype Annotations v2.xlsm
 +
*** all documents for Melanoma patients 02, 03, 11, 12, 14, 16, 24, 27, 41, 44 for a total of 229 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\melanoma\testSet); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\melanoma\testSet\DeepPhe TestSet Phenotype Annotations.xlsm
 +
*** all documents for Ovarian Cancer patients 15, 21, 33, 36, 40, 45, 49, 50 for a total of 559 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\ovarian\final_dataset\testSet); gold annotations are in \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\ovarian\final_dataset\testSet\DeepPhe_ovCa_Test_Set_Phenotype_Annotations_GOLD.xlsm
 +
*** all documents for Colorectal cancer patients 6, 7, 14, 15, 22, 23, 30, 31, 38, 39, 46, 47, 54, 55, 62, 63, 70, 71, 78, 79, 86, 87, 94, 95, 102, 103, 110, 111, 118, 119, 126, 127, 134, 135, 142, 143, 150, 151, 158, 159, 166, 167, 174, 175, 182, 183, 190, 191, 198, 199, 206, 207, 214, 215
 +
** use the training set for developing the algorithms and the development set to report results and error analysis. The test set will be used only for the final evaluation to go in publications.
 +
* [[SEER_Project_Splits| SEER Project Train/Dev/Test Splits]]
 +
* [[Clinical Genomics Gold Set | Clinical Genomics Gold Set ]]
  
== Scrum Sprints ==
+
=== Qualitative Interviews ===
* [https://trello.com/ Sprint Story Boards]
+
* [[User_Personae | Detailed Stakeholder Descriptions]].  
*  [https://docs.google.com/forms/d/1ecotVLQFwGt7ykif8P0IoAtpFl5JiHHW9s4uEXaNQ90/viewform Standup Form]
+
* [[Interview_Protocol | Interview Protocol]]
*[[ScrumSprint_1 | Sprint 1]]
+
* [[Media:Cd-quick-intro-201408110918.pdf|Contextual Design Notes]]
*[[ScrumSprint_2 | Sprint 2]]
+
* [[Informant_Interviews | Notes on interviews with informants]]
*[[ScrumSprint_3 | Sprint 3]]
+
  
  
 +
=== Software Development Goals: Phase 2 ===
 +
* [[phase_2_user_software_goal | Software development goals for the 2nd phase of funding (2020-2025)]]
 +
* [[Expert_informant_feedback | Feedback from Clinical Informants regarding visualization  ]]
 +
* [[phase_2_user_stories | Phase 2 user stories for visualization]]
 +
* [[DeepPhe-Viz-Tasks_Phase 2 | DeepPhe-Viz Tasks]]
 +
* [[dpv_design_suggestions| Other Design Suggestions]]
 +
* [[Unresolved Visualization Design Questions]]
  
== Meeting Notes ==
+
=== Scrum Sprints ===
*[[Modeling_DeepPhe_Meeting_08032015| August 3, 2015]] Modeling Meeting
+
* [[Previous sprints]]
*[[Modeling_DeepPhe_Meeting_07202015| July 20, 2015]] Modeling Meeting
+
*[[Year1_goals_DeepPhe_Sept2020_Aug2021 | Goals DeepPhe Sept 2020 - Aug 2021]]
*[[DeepPhe_Meeting_07072015 | July 7, 2015]] Bi-weekly team meeting
+
**[[Sprint_1_DeepPhe | Sprint 1 DeepPhe, Dec 3, 2020 - Jan 6, 2021]]
*[[DeepPhe_Meeting_07012015 | July 1, 2015]] Scrum Sprint - 1
+
**[[Sprint_2_DeepPhe | Sprint 2 DeepPhe, Jan 7 - Feb 25, 2021]]
*[[DeepPhe_Meeting_06262015 | June 26, 2015]] Software architecture meeting
+
**[[Sprint_3_DeepPhe | Sprint 3 DeepPhe, Feb 25 - Mar 25, 2021]]
*[[DeepPhe_Meeting_06232015 | June 23, 2015]] Bi-weekly team meeting
+
**[[Sprint_4_DeepPhe | Sprint 4 DeepPhe, Mar 25 - Apr 28, 2021]]
*[[DeepPhe_Meeting_06092015 | June 9, 2015]] Bi-weekly team meeting
+
**[[Sprint_5_DeepPhe | Sprint 5 DeepPhe, Apr 29 - May 27, 2021]]
*[[DeepPhe_Meeting_05122015 | May 12, 2015]] Team meeting:DeepPhe demo
+
**[[Sprint_6_DeepPhe | Sprint 6 DeepPhe, May 28 - Jun 24, 2021]]
*[[DeepPhe_Meeting_05052015 | May 5, 2015]] Team meeting:DeepPhe demo
+
**[[Sprint_7_DeepPhe | Sprint 7 DeepPhe, Jun 25 - Jul 22, 2021]]
*[[DeepPhe_Meeting_04282015 | April 28, 2015]] Bi-weekly team meeting
+
**[[Sprint_8_DeepPhe | Sprint 8 DeepPhe, Jul 23 - Aug 19, 2021]]
*[[DeepPhe_Meeting_04132015 | April 13, 2015]] Bi-weekly team meeting
+
**[[Sprint_9_DeepPhe | Sprint 9 DeepPhe, Aug 20 - Sept 16, 2021]]
*[[DeepPhe_Meeting_03172015 | March 17, 2015]] Bi-weekly team meeting
+
*[[Year2_goals_DeepPhe_Sept2021_Aug2022 | Goals DeepPhe Sept 2021 - Aug 2022]]
*[[DeepPhe_Meeting_02232015 | February 23, 2015]] Model prioritization meeting
+
**[[Sprint_10_DeepPhe | Sprint 10 DeepPhe, Sept 17 - Oct 14, 2021]]
*[[DeepPhe_Meeting_02172015 | February 17, 2015]] Bi-weekly team meeting
+
**[[Sprint_11_DeepPhe | Sprint 11 DeepPhe, Oct 14 - Nov 11, 2021]]
*[[DeepPhe_Meeting_02032015 | February 3, 2015]] Bi-weekly team meeting
+
**[[Sprint_12_DeepPhe | Sprint 12 DeepPhe, Nov 12 - Dec 9, 2021]]
*[[BCH_DeepPhe_Meeting_01282015 | January 28, 2015]] BCH team meeting
+
**[[Sprint_13_DeepPhe | Sprint 13 DeepPhe, Dec 10, 2021 - Jan 13, 2022]]
*[[DeepPhe_Meeting_01202015 | January 20, 2015]] Bi-weekly team meeting
+
**[[Sprint_14_DeepPhe | Sprint 14 DeepPhe, Jan 14 - Feb 10, 2022]]
*[[DeepPhe_Meeting_01062015 | January 6, 2015]] Bi-weekly team meeting
+
**[[Sprint_15_DeepPhe | Sprint 15 DeepPhe, Feb 11 - Mar 10, 2022]]
*[[DeepPhe_Meeting_12092014 | December 9, 2014]] BCH team meeting
+
**[[Sprint_16_DeepPhe | Sprint 16 DeepPhe, Mar 11 - April 8, 2022]]
*[[DeepPhe_Meeting_12072014_a | December 9, 2014]] Bi-weekly team meeting
+
**[[Sprint_17_DeepPhe | Sprint 17 DeepPhe, April 8 - May 5, 2022]]
*[[BCH_DeepPhe_Meeting_11202014 | November 20, 2014]] BCH team meeting
+
**[[Sprint_18_DeepPhe | Sprint 18 DeepPhe, May 12 - June 9, 2022]]
*[[DeepPhe_Meeting_11112014_a | November 11, 2014]] Bi-weekly team meeting
+
**[[Sprint_19_DeepPhe | Sprint 19 DeepPhe, June 10 - July 7, 2022]]
*[[DeepPhe_Meeting_11112014 | November 11, 2014]] BCH team meeting
+
**[[Sprint_20_DeepPhe | Sprint 20 DeepPhe, July 8 - Aug 5, 2022]]
*[[DeepPhe_Meeting_11042014 | November 4, 2014]] BCH team meeting
+
**[[Sprint_21_DeepPhe | Sprint 21 DeepPhe, Aug 5 - Sept 1, 2022]]
*[[DeepPhe_Meeting_11032014 | November 3, 2014]] PI meeting
+
*[[Year3_goals_DeepPhe_Sept2022_Aug2023 | Goals DeepPhe Sept 2022 - Aug 2023]]
*[[DeepPhe_Meeting_10272014 | October 27, 2014]] Bi-weekly team meeting: Avillach's presentation on tranSMART, cTAKES and PCORI
+
**[[Sprint_22_DeepPhe | Sprint 22 DeepPhe, Sept 2 - 30, 2022]]
*[[DeepPhe_Meeting_10142014 | October 14, 2014]] Bi-weekly team meeting: agenda and notes
+
**[[Sprint_23_DeepPhe | Sprint 23 DeepPhe, Sept 30 - Nov 30, 2022]]
*[[DeepPhe_Meeting_09302014 | September 30, 2014]] Bi-weekly team meeting: agenda and notes
+
**[[Sprint_24_DeepPhe | Sprint 24 DeepPhe, Dec 1, 2022 - Jan 5, 2023]]
*[[DeepPhe_Meeting_09022014 | September 2, 2014]] Bi-weekly team meeting: agenda and notes
+
**[[Sprint_25_DeepPhe | Sprint 25 DeepPhe, Jan 6 - Feb 2, 2023]]
*[[DeepPhe_Meeting_08192014 | August 19, 2014]] Bi-weekly team meeting: agenda and notes
+
**[[Sprint_26_DeepPhe | Sprint 26 DeepPhe, Feb 3 - Mar 2, 2023]]
*[[DeepPhe_Meeting_08052014 | August 5, 2014]] Bi-weekly team meeting: agenda and notes
+
**[[Sprint_27_DeepPhe | Sprint 27 DeepPhe, Mar 3 - 30, 2023]]
*[[DeepPhe_Meeting_07222014 | July 22, 2014]] Bi-weekly team meeting: agenda and notes
+
**[[Sprint_28_DeepPhe | Sprint 28 DeepPhe, Mar 31 - Apr 27, 2023]]
*[[DeepPhe_Meeting_07162014 | July 15, 2014]] Bi-weekly team meeting: agenda and notes
+
**[[Sprint_29_DeepPhe | Sprint 29 DeepPhe, Apr 28 - May 25, 2023]]
*[[DeepPhe_Harvard_Meeting_07102914 | July 10, 2014]] Hochheiser visit to Savova group
+
**[[Sprint_30_DeepPhe | Sprint 30 DeepPhe, May 26 - June 30, 2023]]
*[[DeepPhe_Meeting_06242014 | June 24, 2014]] Bi-weekly team meeting: agenda and notes
+
**[[Sprint_31_DeepPhe | Sprint 31 DeepPhe, Jul 1 - Aug 3, 2023]]
*[[DeepPhe_Meeting_06102014 | June 10, 2014]] Bi-weekly team meeting: agenda and notes
+
**[[Sprint_32_DeepPhe | Sprint 32 DeepPhe, Aug 3 - 31, 2023]]
*[[DeepPhe_Meeting_05272014 | June 3, 2014]] All hands kick-off meeting
+
*[[Year4_goals_DeepPhe_Sept2023_Aug2024 | Goals DeepPhe Sept 2023 - Aug 2024]]
*[[DeepPhe_Meeting_05082014 | May 08, 2014]] NCIP collaboration with UT (Bermstram/Xu)
+
**[[Sprint_33_DeepPhe | Sprint 33 DeepPhe, Aug 31 - Sep 28, 2023]]
 +
**[[Sprint_34_DeepPhe | Sprint 34 DeepPhe, Sep 29 - Oct 26, 2023]]
 +
**[[Sprint_35_DeepPhe | Sprint 35 DeepPhe, Oct 27 - Nov 30, 2023]]
 +
**[[Sprint_36_DeepPhe | Sprint 36 DeepPhe, Nov 30, 2023 - Jan 4, 2024]]
 +
**[[Sprint_37_DeepPhe | Sprint 37 DeepPhe, Jan 5 - Feb 1, 2024]]
 +
**[[Sprint_38_DeepPhe | Sprint 38 DeepPhe, Feb 2 - 29, 2024]]
 +
**[[Sprint_39_DeepPhe | Sprint 39 DeepPhe, Mar 1 - 28, 2024]]
 +
**[[Sprint_40_DeepPhe | Sprint 40 DeepPhe, Mar 29 - Apr 26, 2024]]
  
 +
=== Project materials/ WIKIs to tasks ===
 +
* [[Archive]]
 +
<!-- *[[UG3 Technical Details]]-->
  
 +
=== Communication ===
 +
* Weekly team meetings
 +
* Tools we use for communication are listed in our [[Communications_Plan |Communications Plan ]].
  
== Licensing ==
+
=== Meeting Notes ===
 
+
* [[Meeting notes]]
[[Licensing| Licensing policies]] for DeepPhe software and ontological models.
+
<!-- == Scrum Sprints == -->
 
+
<!-- * [[Previous sprints]]-->
  
 +
<!-- *[[Year1_goals_DeepPheCR | Goals DeepPhe-CR July 2019 - June 2020]]-->
 +
<!-- *[[ScrumSprint_DeepPheCR | Sprint 1 DeepPhe-CR, August 2019]]-->
 +
<!-- *[[ScrumSprint_DeepPheCR_2 | Sprint 2 DeepPhe-CR, Sept 19 - Oct 17, 2019]]-->
 +
<!-- *[[ScrumSprint_DeepPheCR_3 | Sprint 3 DeepPhe-CR, Oct 18 - Nov 14, 2019]]-->
 +
<!-- *[[ScrumSprint_DeepPheCR_4 | Sprint 4 DeepPhe-CR, Nov 14 - Jan 9, 2020]]-->
 +
<!-- *[[ScrumSprint_DeepPheCR_5 | Sprint 5 DeepPhe-CR, Jan 9 - Feb 6, 2020]]-->
 +
<!-- *[[ScrumSprint_DeepPheCR_6 | Sprint 6 DeepPhe-CR, Feb 7 - Mar 5, 2020]]-->
 +
<!-- *[[ScrumSprint_DeepPheCR_7 | Sprint 7 DeepPhe-CR, Mar 6 - Apr 2, 2020]]-->
 +
<!-- *[[ScrumSprint_DeepPheCR_8 | Sprint 8 DeepPhe-CR, Apr 3 - May 1, 2020]]-->
  
 
== Contact ==
 
== Contact ==
If you need assistance and/or if you have questions about the project, feel free to send e-mail to Guergana.Savova at childrens dot harvard dot edu or to Rebecca Crowley Jacobson at rebeccaj at pitt dot edu
+
<!-- If you need assistance or if you have further questions about the project, contact us at the [https://groups.google.com/forum/#!forum/deepphe DeepPhe group].-->
 
+
If you have further questions about the project, contact guergana dot savova at childrens dot harvard dot edu.
  
  

Revision as of 17:37, 2 April 2024


Welcome to the Cancer Deep Phenotype Extraction project

Our goal is to develop novel methods for information extraction to facilitate automatic/unsupervised/minimally supervised extraction of specific discrete cancer-related data from various types of unstructured electronic medical records. Our two main use cases are cancer deep phenotyping for translational science (DeepPhe) and a platform for cancer surveillance by the cancer registries (DeepPhe*CR)


Who We Are

Boston Children's Hospital/Harvard Medical School

  • Guergana Savova (MPI for DeepPhe and DeepPhe*CR)
  • Timothy Miller
  • Sean Finan
  • David Harris
  • Chen Lin
  • past members -- Dmitriy Dligach (currently faculty at Loyola University, Chicago), James Masanz

University of Pittburgh

  • Harry Hochheiser (MPI for DeepPhe and DeepPhe*CR)
  • Zhou Yuan
  • John Levander
  • past members - through June 2017: Rebecca Crowley Jacobson (MPI), Roger Day, Adrian Lee, Robert Edwards, John Kirkwood, Kevin Mitchell, Eugene Tseytlin, Girish Chavan, Melissa Castine; Liz Legowski (through Jan 2015), Olga Medvedeva, Mike Davis

Rhode Island Hospital (Brown University)

University of Kentucky/Kentucky Cancer Registry

  • Eric Durbin (MPI for DeepPhe*CR)
  • Isaac Hands
  • Jong Jeong
  • Ramakanth (Rama) Kavuluru
  • David Rust
  • Lisa Witt

Dana-Farber Cancer Institute

University of Minnesota

  • Piet de Groen

Vanderbilt University

Funding

The project described is supported by the National Cancer Institute at the US National Institutes of Health. It is part of the National Cancer Institute's Informatics Technology for Cancer Research (ITCR) Initiative (http://itcr.nci.nih.gov/) and the Surveillance, Epidemiology, and End Results Program (SEER; https://seer.cancer.gov/) at the US National Cancer Institute (NCI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.


Cancer Deep Phenotyping for Cancer Surveillance (DeepPhe*CR)

Scrum Sprints

Project materials

Publications and presentations

Peer-reviewed publications:

  1. 2023: Bitterman DS, Goldner E, Finan S, Harris D, Durbin EB, Hochheiser H, Warner JL, Mak RH, Miller T, Savova GK. An End-to-End Natural Language Processing System for Automatically Extracting Radiation Therapy Events From Clinical Texts. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):262-273. doi: 10.1016/j.ijrobp.2023.03.055. Epub 2023 Mar 27. PMID: 36990288; PMCID: PMC10522797.
  2. 2020: Durbin, Eric; Hochheiser , Harry; Petkov, Valentina; Rivera, Donna; Savova, Guergana; Warner, Jeremy. 2020. Tools and software to automate and normalize the cancer data abstraction workflow. Workshop at the annual North American Association of Cancer Registries (NAACCR). June 2020. Philadelphia, PA.
  3. 2020: Zhou Yuan, Sean Finan, Jeremy Warner, Guergana Savova, Harry Hochheiser 2019. Interactive Exploration of Longitudinal Cancer Patient Histories Extracted From Clinical Text. JCO Clin Cancer Inform. 2020 May;4:412-420. doi: 10.1200/CCI.19.00115
  4. 2019: Guergana Savova, Ioana Danciu, Folami Alamudun, Timothy Miller, Chen Lin, Danielle S Bitterman, Georgia Tourassi and Jeremy L Warner. 2019. Use of Natural Language Processing to Extract Clinical Cancer Phenotypes from Electronic Medical Records. Cancer Research. doi: 10.1158/0008-5472.CAN-19-0579

Pre-prints:

  1. 2023: Hochheiser H, Finan S, Yuan Z, Durbin EB, Jeong JC, Hands I, Rust D, Kavuluru R, Wu XC, Warner JL, Savova G. DeepPhe-CR: Natural Language Processing Software Services for Cancer Registrar Case Abstraction. medRxiv [Preprint]. 2023 Oct 26:2023.05.05.23289524. doi: 10.1101/2023.05.05.23289524. PMID: 37205575; PMCID: PMC10187451.

Presentations:

  1. 2019: Savova, Guergana and Hochheiser, Harry. “Cancer Deep Phenotype Extraction from Electronic Medical Records ”. Data Science Seminar Series. National Cancer Institute, National Institutes of Health. Oct 2019.
  2. 2019: Warner, Jeremy, Durbin, Eric, Petkov, Valentina and Savova, Guergana. 2019. Tools and Software to Automate and Normalize the Cancer Data Abstraction Workflow. Workshop at 2019 Conference of the North American Association of Central Cancer Registries and the International Association of Cancer Registries. June 9-13, 2019. Vancouver, BC, Canada

Websites

Cancer Deep Phenotyping for Translational Science (DeepPhe)

Publications and presentations

Peer-reviewed publications:

    1. Lin, Chen; Miller, Timothy; Dligach, Dmitriy; Amiri, Hadi; Bethard, Steven and Savova, Guergana. 2018. Self-training improves Recurrent Neural Networks performance for Temporal Relation Extraction. LOUHI 2018: The Ninth International Workshop on Health Text Mining and Information Analysis. Oct 31-Nov 1, 2018. Brussels, Belgium. https://aclanthology.coli.uni-saarland.de/papers/W18-5619/w18-5619
    2. Malty, Andrew M., Jain, Sandeep K., Yang, Peter C., Harvey, Krysten, Warner, Jeremy L. Computerized approach to creating a systematic ontology of hematology/oncology regimens. JCO Clinical Cancer Informatics. 2018 May 11. http://ascopubs.org/doi/full/10.1200/CCI.17.00142
    3. Miller, Timothy; Dligach, Dmitriy; Bethard, Steven; Lin, Chen; Savova, Guergana. 2017. Towards Generalizable Entity-Centric Clinical Coreference Resolution. Journal of Biomedical Informatics. Vol. 69, May 2017, pp. 251-258. https://doi.org/10.1016/j.jbi.2017.04.015; http://www.sciencedirect.com/science/article/pii/S1532046417300850
    4. Castro SM, Tseytlin E, Medvedeva O, Mitchell K, Visweswaran S, Bekhuis T, Jacobson RS. 2017. Automated annotation and classification of BI-RADS assessment from radiology reports. J Biomed Inform. 2017 May;69:177-187. doi: 10.1016/j.jbi.2017.04.011. PMID: 28428140; PMCID: PMC5706448 [Available on 2018-05-01] DOI:10.1016/j.jbi.2017.04.011 https://www.sciencedirect.com/science/article/pii/S1532046417300813
    5. Lin, Chen; Miller, Timothy; Dligach, Dmitriy; Bethard, Steven; Savova, Guergana. 2017. Representations of Time Expressions for Temporal Relation Extraction with Convolutional Neural Networks. BioNLP workshop at the Association for Computational Linguistics conference. Vancouver, Canada, Friday August 4, 2017. https://aclanthology.coli.uni-saarland.de/papers/W17-2341/w17-2341
    6. Miller, T; Bethard, S; Amiri, H; Savova, G. 2017. Unsupervised Domain Adaptation for Clinical Negation Detection. BioNLP workshop at the Association for Computational Linguistics conference. Vancouver, Canada, Friday August 4, 2017 https://aclanthology.coli.uni-saarland.de/papers/W17-2320/w17-2320
    7. Savova, G., Tseytlin, E., Finan, S., Castine, M., Miller, T., Medvedeva, O., Haris, D., Hochheiser, H., Lin, C., Chavan, G., Jacobson R. 2017. DeepPhe - A Natural Language Processing System for Extracting Cancer Phenotypes from Clinical Records. Annual Symposium of the American Medical Informatics Association (AMIA). Nov 2017. Washington DC https://amia2017.zerista.com/event/member/389439
    8. Savova, G., Tseytlin, E., Finan, S., Castine, M., Miller, T., Medvedeva, O., Haris, D., Hochheiser, H., Lin, C., Chavan, G., Jacobson R. 2017. DeepPhe: A Natural Language Processing System for Extracting Cancer Phenotypes from Clinical Records. Cancer Research 77(21), November 2017 DOI: 10.1158/0008-5472.CAN-17-0615. https://www.ncbi.nlm.nih.gov/pubmed/29092954
    9. Dligach, Dmitriy; Miller, Timothy; Lin, Chen; Bethard, Steven; Savova, Guergana. 2017. Neural temporal relation extraction. European Chapter of the Association for Computational Linguistics (EACL 2017). April 3-7, 2017. Valencia, Spain. https://aclanthology.coli.uni-saarland.de/papers/E17-2118/e17-2118
    10. Chen, Lin; Miller, Timothy; Dligach, Dmitriy; Bethard, Steven; Savova, Guergana. 2016. Improving Temporal Relation Extraction with Training Instance Augmentation. BioNLP workshop at the Association for Computational Linguistics conference. Berlin, Germany, Aug 2016 https://aclanthology.coli.uni-saarland.de/papers/W16-2914/w16-2914
    11. Hochheiser, Harry; Castine, Melissa; Harris, David; Savova, Guergana; Jacobson, Rebecca. 2016. An Information Model for Computable Cancer Phenotypes. BMC Medical Informatics and Decision Making. https://bmcmedinformdecismak.biomedcentral.com/articles/10.1186/s12911-016-0358-4 https://www.ncbi.nlm.nih.gov/pubmed/27629872
    12. Ethan Hartzell, Chen Lin. 2016. Enhancing Clinical Temporal Relation Discovery with Syntactic Embeddings from GloVe. International Conference on Intelligent Biology and Medicine (ICIBM 2016). Medical Informatics Thematic Track. December 2016, Houston, Texas, USA
    13. Dmitriy Dligach, Timothy Miller, Guergana K. Savova. 2015. Semi-supervised Learning for Phenotyping Tasks. AMIA Annual Symposium. Nov 2015, San Francisco, CA. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765699/
    14. Chen, Lin; Dligach, Dmitriy; Miller, Timothy; Bethard, Steven; Savova, Guergana. 2015. Multilayered temporal modeling for the clinical domain. Journal of the American Medical Informatics Association. 2016 Mar;23(2):387-95. doi: 10.1093/jamia/ocv113 https://www.ncbi.nlm.nih.gov/pubmed/26521301

Peer-reviewed other:

    1. Beeghly-Fadiel, Alicia; Warner, Jeremy; Finan, Sean; Masanz, James; Hochheiser, Harry; Savova, Guergana. (under review). Deep Phenotype Extraction to Facilitate Cancer Research: Extending DeepPhe to Ovarian Cancer. American Association for Cancer Research (AACR) 2019. March 29-April 3, 2019. Atlanta, GA.
    2. Yuan, Zhou; Finan, Sean; Warner, Jeremy; Savova, Guergana; Hochheiser, Harry. 2018. Toward Longitudinal Visual Analytics for Cancer Patient Trajectories Extracted from Clinical Text. 2018 Workshop on Visual Analytics and Healthcare, Demonstration Presentation. AMIA 2018, Nov 3-7, 2018. San Francisco, CA.
    3. Chen Lin, Timothy A. Miller, Hadi Amiri, David Harris, Samuel M. Rubinstein, Jeremy Warner, Guergana K. Savova, Ph.D. 2018. Classification of electronic medical records of breast cancer and melanoma patients into clinical episodes. 30th Anniversary AACR Special Conference Convergence: Artificial Intelligence, Big Data, and Prediction of Cancer. Oct 14-17, 2018. Newport, RI, USA.
    4. Warner, Jeremy; Elhadad, Noemie; Bastarache, Lisa; Gotz, David; Savova, Guergana. 2018. Panel - Didactic: Computable Longitudinal Patient Trajectories. Annual Symposium of the American Medical Informatics Association. November, 2018. San Francisco, CA. (peer-reviewed panel)
    5. Savova G, Tseytlin E, Finan S, Castine M, Miller T, Medvedeva O, Harris D, Hochheiser H, Lin C, Chavan G, Warner JL, Jacobson R. DeepPhe – a natural language processing system for extracting cancer phenotypes from clinical records. Annual conference of the North American Association of Central Cancer Registries (NAACCR). Pittsburgh, PA.
    6. Warner JL, Harris D, Rubinstein S, Finan S, Lin C, Miller T, Amiri H, Hochheiser H, Savova G. Capturing high-resolution temporal cancer phenotypes using DeepPhe. Annual conference of the North American Association of Central Cancer Registries (NAACCR). Pittsburgh, PA.
    7. Yang PC, Malty A, Jain SK, Harvey K, Finan S, Warner JL. 2018. A Comprehensive Ontology of Hematology/Oncology Regimens. Annual conference of the North American Association of Central Cancer Registries (NAACCR). Pittsburgh, PA.
    8. Hochheiser H; Jacobson R; Washington N; Denny J; Savova G. 2015. Natural language processing for phenotype extraction: challenges and representation. AMIA Annual Symposium. Nov 2015, San Francisco, CA. (peer-reviewed panel)

Invited presentations:

    1. Savova, Guergana. 2019. Cancer Deep Phenotype Extraction from Electronic Medical Records. Molecular Med Tri-con. March 10-15, 2019. San Francisco, CA, USA
    2. Savova G. 2018. Software and Research Challenges for Clinical NLP. Dana Farber Cancer Institute; 2018 October; Boston, MA, USA.
    3. Savova, Guergana. 2018. Cancer Deep Phenotype Extraction form Electronic Medical Records (DeepPhe). College of American Pathologists Pathology Electronic Reporting meeting (CAP PERT). July 29, 2018. Montreal, QB, CA.
    4. Warner, Jeremy. 2018. A Comprehensive Ontology of Hematology/Oncology Regimens. College of American Pathologists Pathology Electronic Reporting meeting (CAP PERT). July 29, 2018. Montreal, QB, CA.
    5. Savova, G; Miller, T. 2018. DeepPhe and Extraction of Oncology Patient Phenotypes from Unstructured Text Using NLP and Other AI Tools. Presentation to Dana Farber Cancer Institute. January 24 2018. Boston, MA.
    6. Warner, Jeremy. 2017. Supporting cancer registries through automated extraction of pathology and chemotherapy regimen information.” CDC/NCI/FDA/VA Clinical Natural Language Processing Workshop. Atlanta, GA.
    7. Savova, Guergana. 2017. Select Applications of Natural Language Processing in Biomedicine. Natural Language Processing Symposium, Boston University, Boston, MA. November, 2017.
    8. Jacobson, Rebecca. 2017. Invited presentation at Ohio State University James Cancer Center Grand Rounds, January 20th, 2017
    9. Jacobson, Rebecca. 2017. Invited presentation at Case Western University Comprehensive Cancer Center Seminar Series, March 10th, 2017
    10. Jacobson, Rebecca. 2016. Invited presentation of cTAKES and DeepPhe to NCI in January, 2016. Gaithersburg, MD
    11. Jacobson, Rebecca. 2016. Invited presentation in CBIIT Speaker Series, February 17, 2016. Gaithersburg, MD
    12. Jacobson, Rebecca. 2016. Invited presentation at University of Pittsburgh Cancer Informatics (UPCI) External Advisory Board, March 8, 2016
    13. Finan, Sean. 2016. cTAKES/deepPhe presentation at the ITCR workshop at CI4CC in Napa, CA
    14. Jacobson, Rebecca. 2016. Invited presentation at SEER PI meeting in New Mexico, March 16, 2016
    15. Jacobson, Rebecca. 2016. Invited presentation at University of Michigan Department of Learning Health Sciences, April 6th, 2016
    16. Jacobson, Rebecca. 2016. Invited presentation at Pathology Informatics 2016, Pittsburgh PA, May 24th, 2016
    17. Jacobson, Rebecca. 2016. Invited presentation at University of Pittsburgh Cancer Institute Scientific Retreat, Greensburg, PA, June 16th, 2016
    18. Jacobson, Rebecca and Savova, Guergana. 2016. Invited presentation at SEER meeting in Gaithersburg, MD, December 10, 2016
    19. Jacobson, Rebecca and Savova, Guergana. Invited presentation of cTAKES/DeepPhe to NCI in October, 2015

Other:


Information Extracted by DeepPhe

  • Cancer – body location, laterality, stage, clinical TNM, path TNM
  • Tumor – body location, laterality, diagnosis, tumor type, histologic type, cancer type, extend, grade
  • Specific to BrCA – clockface position, quadrant, ER/PR/HER2
  • Specific to OvCa – CA-125
  • Specific to melanoma – clarks level, Breslow depth
  • Specific to prostate cancer -- Gleason score, PSA
  • Medications
  • Procedures
  • Radiotherapy
  • Comorbidities
  • Episodes –
    • Pre-diagnostic: a tumor is mentioned PRIOR to a malignant diagnosis
    • Diagnostic: a tumor is mentioned WITH a malignant diagnosis
    • Decision making: discussion of potential treatments AFTER an established diagnosis
    • Treatment: a treatment is mentioned DURING the treatment episode
    • Follow-up: discussion appearing AFTER the treatment episode ends
    • Unknown: episode category unsettled

DeepPhe Software

DeepPhe release is available in

DeepPhe Gold Set

  • Process for Deidentification of Source Documents.
  • Process for Deidentification of Source Documents.
  • Process for Deidentification of Source Documents.
  • Process for Selection of Gold Set Source Documents.
  • DepPhe Training/Development/Test splits
    • training set:
      • all documents for Breast Cancer patients 03, 11, 92, 93 for a total of 48 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev\DeepPhe Gold Phenotype Annotations_v2.xlsm
      • all documents for Breast Cancer patients extended 4,5,6,9,10,12,13,14,18,19,20,22,23,26,27,30,31,32,33,34,35,38,39,40,41,42,43,46,47 for a total of 954 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev\DeepPhe Gold Phenotype Annotations_v2.xlsm
      • all documents for Melanoma patients 05, 06, 18, 19, 25, 28, 30, 33, 34, 42, for a total of 233 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\melanoma); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\melanoma\trainSet\DeepPhe DevSet Phenotype Annotations.xlsm
      • all documents for Ovarian Cancer patients 3, 4, 7, 8, 12, 13, 16, 17, 18, 20, 24, 25, 26, 27, 30, 31, 32, 34, 37, 38, 41, 42, 43, 44, 46, 48 for a total of 1675 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\ovarian\final_dataset\trainSet); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\ovarian\final_dataset\trainSet\DeepPhe_ovCa_Train_Set_Phenotype_Annotations_GOLD.xlsm
      • all documents for Colorectal cancer patients 1, 2, 3, 8, 9, 10, 11, 16, 17, 18, 19, 24, 25, 26, 27, 32, 33, 34, 35, 40, 41, 42, 43, 48, 49, 50, 51, 56, 57, 58, 59, 64, 65, 66, 67, 72, 73, 74, 75, 80, 81, 82, 83, 88, 89, 90, 91, 96, 97, 98, 99, 104, 105, 106, 107, 112, 113, 114, 115, 120, 121, 122, 123, 128, 129, 130, 131, 136, 137, 138, 139, 144, 145, 146, 147, 152, 153, 154, 155, 160, 161, 162, 163, 168, 169, 170, 171, 176, 177, 178, 179, 184, 185, 186, 187, 192, 193, 194, 195, 200, 201, 202, 203, 208, 209, 210, 211, 216, 217
    • development set:
      • all documents for Breast Cancer patients 02, 21 for a total of 42 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev\DeepPhe Gold Phenotype Annotations_v2.xlsm
      • all documents for Breast Cancer patients extended 7,8,15,16,17,24,25,28,29,36,37,44,45 for a total of 457 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedDev\DeepPhe Gold Phenotype Annotations_v2.xlsm
      • all documents for Melanoma patients 07, 32, 43 for a total of 215 (processed only 211 docs) documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\melanoma\devSet); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\melanoma\devSet\DeepPhe DevSet Phenotype Annotations.xlsm
      • all documents for Ovarian Cancer patients 9, 11, 19, 28, 29, 35, 39, 47 for a total of 562 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\ovarian\final_dataset\devSet); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\ovarian\final_dataset\devSet\DeepPhe_ovCa_Dev_Set_Phenotype_Annotations_GOLD.xlsm
      • all documents for Colorectal cancer patients 4, 5, 12, 13, 20, 21, 28, 29, 36, 37, 44, 45, 52, 53, 60, 61, 68, 69, 76, 77, 84, 85, 92, 93, 100, 101, 108, 109, 116, 117, 124, 125, 132, 133, 140, 141, 148, 149, 156, 157, 164, 165, 172, 173, 180, 181, 188, 189, 196, 197, 204, 205, 212, 213
    • test set:
      • all documents for Breast Cancer patients 01 (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedTest); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedTest\DeepPhe Test Phenotype Annotations v2.xlsm
      • all documents for Breast Cancer extended for patients 01, 02, 63, 76, 100, 101, 104, 106, 109, 111, 114, 115, 117, 118, 119, 120, 121, 123, 125, 126, 129, 130, 132, 136, 137, 138, 142, 143, 155, 156, 158, 174, 181, 189, 197 for phenotyping level testing use (\\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedTest\); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\breast\UPMCextendedTest\DeepPhe Test Phenotype Annotations v2.xlsm
      • all documents for Melanoma patients 02, 03, 11, 12, 14, 16, 24, 27, 41, 44 for a total of 229 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\melanoma\testSet); gold annotations are \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\melanoma\testSet\DeepPhe TestSet Phenotype Annotations.xlsm
      • all documents for Ovarian Cancer patients 15, 21, 33, 36, 40, 45, 49, 50 for a total of 559 documents (in BCH \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\ovarian\final_dataset\testSet); gold annotations are in \\rc-fs\chip-nlp\Public\DeepPhe\DeepPheDatasets\ovarian\final_dataset\testSet\DeepPhe_ovCa_Test_Set_Phenotype_Annotations_GOLD.xlsm
      • all documents for Colorectal cancer patients 6, 7, 14, 15, 22, 23, 30, 31, 38, 39, 46, 47, 54, 55, 62, 63, 70, 71, 78, 79, 86, 87, 94, 95, 102, 103, 110, 111, 118, 119, 126, 127, 134, 135, 142, 143, 150, 151, 158, 159, 166, 167, 174, 175, 182, 183, 190, 191, 198, 199, 206, 207, 214, 215
    • use the training set for developing the algorithms and the development set to report results and error analysis. The test set will be used only for the final evaluation to go in publications.
  • SEER Project Train/Dev/Test Splits
  • Clinical Genomics Gold Set

Qualitative Interviews


Software Development Goals: Phase 2

Scrum Sprints

Project materials/ WIKIs to tasks

Communication

Meeting Notes


Contact

If you have further questions about the project, contact guergana dot savova at childrens dot harvard dot edu.


Getting started

Consult the User's Guide for information on using the wiki software.